Company Culture

Discussion in 'Alimera Sciences' started by anonymous, Mar 18, 2017 at 1:52 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    0.36
     

  2. anonymous

    anonymous Guest

    the problem is: the company thinks that their revenue gain announcements will impact the stock. It won’t. Why? Because it is not hard to do the math. A million dollar gain with a product that cost $10,000 equates to 100 units. That’s around a 2 unit gain per representative over a 3 month period. Throw in Europe sales and it’s less than 2 units per rep, more like 1 unit per rep over a 3 month period. I ask you, how do you celebrate results like that?
     
  3. anonymous

    anonymous Guest

    WeWork on a smaller scale. Mgt & Board grabbing as much cash as they can and running for the border.
     
  4. anonymous

    anonymous Guest

    More stock dilution today on a massive scale. Stockholder equity going going gone....
     
  5. anonymous

    anonymous Guest

    Now they did it. after nine month they 11m loss !"" great job rick .""
    after six years in the EU and four years in US , after 400m loss additionally a second indication outside US.
    you are loss money month after month , howe you find an investor . what promise you give them?
    a seat as a director with bonus salary ?
     
  6. anonymous

    anonymous Guest

    Ok so here’s the facts: we grew our business here in the US Q3 2019 vs. Q3 2018 by 20 units. That’s 20 units over a 3 month period. That’s 7 units per month over a 3 month period. That’s 0.15 unit per rep. The growth came from, once again EU distribution buy-in. That’s it.
     
  7. anonymous

    anonymous Guest

    Too much AR on the balance sheet. I think they have a revenue recognition problem. When do they book revenue ? When an implant is inserted or when the drug is put on the shelf ? When the shelf life expires on an unused implant who eats the $$$$ ??
     
  8. anonymous

    anonymous Guest

     
  9. anonymous

    anonymous Guest

     
  10. anonymous

    anonymous Guest

    0.30
     
  11. anonymous

    anonymous Guest

    0.22
     
  12. anonymous

    anonymous Guest

    TWENTY-TWO Cents!!!
    15:1 reverse split probably won’t be enough to avoid nasdaq delisting as the market cap will be way too low. This is probably the last chance to get off of the ship before it totally sinks. Anyone that had stayed this long is blindly loyal or incredibly stupid. What a dumpster fire.
     
  13. anonymous

    anonymous Guest

    What's 22 cents when you have already lost several dollars ! Stick around for the class action....
     
  14. anonymous

    anonymous Guest

     
  15. anonymous

    anonymous Guest

    this was a great shell game, chapeau rick. ! Now you are on to sell the stock options , hurry up before the sinking ship drive down. The First time as a almiran you can sell the got dam Stock options. So hurry befrore the 4Q shows the bankruptcy all the Investors . Run
     
  16. anonymous

    anonymous Guest

    When are the doors closing on this company?
     
  17. anonymous

    anonymous Guest

    What is wrong with this company?
    How the VP of sales?
    Is the product not good?
     
  18. anonymous

    anonymous Guest

    Omg , now they make another shell game. The „benelux „ wants Iluvien dir the treatment of uveitis, Ha Ha it US so funny . the patients didn‘t get lucentis or eylea for the amd or dme treatment, because ist is to expensive. Nether iluvien hahaha. So now they reimburse it for niu haha. Great Shell Game rick. Château
     
  19. Horatio

    Horatio Guest

    I bought shares just after the reverse share split, largely thanks to the CEO Rick Eisenworth who presented at an investor conference I was at. I have watched my investment double in value in three weeks so I'm really happy. Merry Christmas to all the people who are selling iluvian, keep doing what you are doing!
     
  20. anonymous

    anonymous Guest


    Get to work Rick. You’re not that great